Abbott narrows FY26 adjusted EPS guidance
Abbott reported Q3 financial results and narrowed its FY26 adjusted EPS guidance.
Story updates
12:00:46 PM UTC
SquawkNews
NORTH CHICAGO (dpa-AFX) - While reporting financial results for the third quarter on Wednesday, healthcare company Abbott Laboratories (ABT) provided adjusted earnings guidance for the fourth quarter and reaffirmed its adjusted earnings outlook for the full-year 2026.For the fourth quarter, Abbott…
12:14:26 PM UTC
SquawkNews
Abbott reaffirms and narrows its full-year adjusted diluted EPS guidance to $5.50 to $5.55, tightening around the previously provided midpoint. The company projects full-year comparable sales growth of approximately 6.0%. Chairman and CEO Robert B. Ford attributed third-quarter results to balanced…